C12N 2740/15023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2740/15023 (Virus like particles [vlp]) appears on 39 US grants and 68 published applications in this corpus.
Search patents in C12N- Granted patents
- 39
- Published applications
- 68
- Assignees
- 48
- Inventors
- 180
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 1 | 0 |
| 2015 | 3 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 0 | 2 |
| 2020 | 1 | 4 |
| 2021 | 2 | 6 |
| 2022 | 1 | 10 |
| 2023 | 3 | 4 |
| 2024 | 4 | 7 |
| 2025 | 10 | 11 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for transduction of t cells in the presence of malignant cells4 Aug 2026US 12,698,315 B2Miltenyi Biotec GmbH
- Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells24 Feb 2026US 12,559,769 B2American Gene Technologies International Inc.
- P21 expressing monocytes for cancer cell therapy6 Jan 2026US 12,514,902 B2Institut Gustave Roussy
- Multivalent virus like particle vaccines23 Dec 2025US 12,502,425 B2Texas Tech University System
- Compositions for treating cancer14 Oct 2025US 12,440,564 B2Kelonia Therapeutics, Inc.
- Vector production24 Sep 2026US 2026/0286391 A1Fondazione Telethon Ets
- Composition including virus like particles (vlps), a kit, and method for antitumoral therapy13 Aug 2026US 2026/0234573 A1Cnpem- Centro Nacional De Pesquisa Em Energia E Materiais
- Engineered protein g fusogens and related lipid particles and methods thereof13 Aug 2026US 2026/0234669 A1Sana Biotechnology, Inc.
- Directed evolution of engineered virus-like particles (evlps)23 Jul 2026US 2026/0209747 A1President and Fellows of Harvard College
- Systems and methods for modifying a polynucleotide9 Jul 2026US 2026/0193679 A1Children's Medical Center Corporation
Most cited
By later US patents
- Non-infectious HIV particles lacking long terminal repeats24US 5,439,809 AConnaught Laboratories Limited · 1995
- Virus-like particles, methods of preparation, and immunogenic compositions15US 9,045,727 B2Emory University · 2015
- Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats12US 5,571,712 AConnaught Laboratories Limited · 1996
- Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles12US 7,008,784 B1Aventis Pasteur Limited · 2006
- Pseudotyped viral particles, compositions comprising the same, and uses thereof10US 11,767,366 B1Interius Biotherapeutics, Inc. · 2023